Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas

被引:86
作者
Miyamoto, R [1 ]
Uzawa, N [1 ]
Nagaoka, S [1 ]
Hirata, Y [1 ]
Amagasa, T [1 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Div Maxillofacial & Neck Reconstruct, Bunkyo Ku, Tokyo 1138549, Japan
关键词
fluorescence in situ hybridization (FISH); fine-needle aspiration (FNA); immunohistochemistry (IHC); cyclin D1 (CCND1);
D O I
10.1016/S1368-8375(03)00048-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Amplification and overexpression of cyclin D1 (CCND1) have been reported as independent prognostic indicators of several tumors. To investigate the association between CCND1 amplification and overexpression in oral squamous cell carcinomas (OSCCs), and to determine which is more reliable as a prognostic indicator, fluorescence in situ hybridization (FISH) on fine-needle aspiration (FNA) biopsies and immunohistochemistry were performed on 41 primary OSCCs (26 males, 15 females; mean age; 58.4 years, range 21-89 years). Thirteen patients were stage I, 13 were stage II, nine were stage III, and six were stage IV. CCND1 amplification and overexpression was detected in 13 (31.7%) and 27 (65.9%) of 41 cases. CCND1 was overexpressed in all cases showing CCND1 amplification. On the other hand, CCND1 overexpression was also detected in 14 of 28 cases (50.0%) tacked such amplification. Statistical analysis showed that the correlation between CCND1 overexpression and decreased survival just failed to reach statistical significance, and CCND1 amplification and nodal status were independent prognostic indicators. In conclusion, it will be necessary to investigate the other pathways that regulate CCND1 expression besides CCND1 amplification. From the present study, CCND1 amplification is a more reliable prognostic indicator than CCND1 overexpression in OSCCs. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:610 / 618
页数:9
相关论文
共 35 条
[1]  
Åkervall J, 2002, INT J ONCOL, V20, P45
[2]  
Bellacosa A, 1996, CLIN CANCER RES, V2, P175
[3]  
Bova RJ, 1999, CLIN CANCER RES, V5, P2810
[4]  
Califano J, 1996, CANCER RES, V56, P2488
[5]  
Califano J, 2000, CLIN CANCER RES, V6, P347
[6]   A new role for hypoxia in tumor progression: Induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs [J].
Coquelle, A ;
Toledo, F ;
Stern, S ;
Bieth, A ;
Debatisse, M .
MOLECULAR CELL, 1998, 2 (02) :259-265
[7]   Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons [J].
Coquelle, A ;
Pipiras, E ;
Toledo, F ;
Buttin, G ;
Debatisse, M .
CELL, 1997, 89 (02) :215-225
[8]   High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells [J].
Huang, X ;
Gollin, SM ;
Raja, S ;
Godfrey, TE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11369-11374
[9]  
Ichikawa D, 1996, CANCER, V77, P2064
[10]   Dysregulated cyclin D1 expression early in head and neck tumorigenesis:: in vivo evidence for an association with subsequent gene amplification [J].
Izzo, JG ;
Papadimitrakopoulou, VA ;
Li, XQ ;
Ibarguen, H ;
Lee, JS ;
Ro, JY ;
El-Naggar, A ;
Hong, WK ;
Hittelman, WN .
ONCOGENE, 1998, 17 (18) :2313-2322